Apple Formulations

Delhi, India
Specializes in contract manufacturing of pharmaceutical formulations for clients.

About Apple Formulations

Apple Formulations is a Healthcare company based in Delhi (India). It specializes in contract manufacturing of pharmaceutical formulations for clients. It operates on a B2B model. The company has 80 employees. Its Indian entity Apple Formulations Private Limited. reported revenue of β‚Ή112 Cr. Its focus areas include Pharmaceuticals, Manufacturing and Contract Manufacturing. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.

Company details

Apple Formulations specializes in contract manufacturing of pharmaceutical formulations for clients through providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and contract manufacturing. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Key Metrics
  • Annual Revenue
    ₹112 Cr

    FY 2025 · +3% YoY

  • Net Profit
    ₹2.76 Cr

    FY 2025 · 2% margin

  • EBITDA
    ₹6.91 Cr

    FY 2025 · 6% margin

  • Employee Count
    80

Board of directors of Apple Formulations Private Limited. (Apple Formulations)

Apple Formulations Private Limited. is the primary company behind Apple Formulations. The board of Apple Formulations Private Limited. currently have 4 directors; the longest-serving is Naveen Khaitan, appointed in 2006. 4 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Naveen Khaitan
DIN 00933382
Director06 May 200620 yrs 6 moApple Formulations Private Limited.
Rahul Khaitan
DIN 01527622
Director03 Jul 200620 yrs 4 moApple Formulations Private Limited.
Binod Kumar Jha
DIN 08323312
Director09 Jan 20197 yrs 9 moApple Formulations Private Limited.
Ram Darash Dwivedi
DIN 10139804
Director08 May 20233 yrs 6 moApple Formulations Private Limited.

Financials of Apple Formulations

Figures of Apple Formulations Private Limited., the primary company behind Apple Formulations, for FY 2025. Revenue was ₹112 Cr (+3% year on year). Net profit was ₹2.76 Cr (2% margin). EBITDA was ₹6.91 Cr (6% margin). Revenue has grown at a compounded annual rate of +379% over three years and +12% over five years.

  • ₹112 CrRevenue · FY 2025 · +3% YoY
  • ₹2.76 CrNet profit · 2% margin
  • ₹6.91 CrEBITDA · 6% margin
  • ₹22.6 LakhPaid-up capital
  • 80Employees (provident fund records)
  • +379%Revenue CAGR, 3 years
  • +12%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Apple Formulations Private Limited. are on its company page.

Premium access

Detailed financial statements for Apple Formulations

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Apple Formulations

Apple Formulations has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
akums.in2004Delhi, India$70M395
CDMO focusing on spectrum of dosage forms and therapeutic segments
jubl.com1978Noida, India
Company offering a suite of R&D and manufacturing services for small molecules and generics
neclife.com1995Chandigarh, India$46.85M175
Cephalosporin APIs and generic formulations are manufactured.
Premium access

Detailed similar companies of Apple Formulations

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Apple Formulations

Apple Formulations is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

Apple Formulations has 80 employees.

The primary company behind Apple Formulations, Apple Formulations Private Limited., reported revenue of β‚Ή112 Cr for FY 2025, up 3% year on year.

Apple Formulations specializes in contract manufacturing of pharmaceutical formulations for clients through providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and contract manufacturing. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Apple Formulations's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.

Apple Formulations operates through Apple Formulations Private Limited..

The legal entities of Apple Formulations currently have 4 directors, including Rahul Khaitan, Naveen Khaitan, Binod Kumar Jha and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available